Oral vancomycin and gentamicin for treatment of very early onset inflammatory bowel disease
Background: The pathogenesis of inflammatory bowel disease (IBD) is complex and involves the contribution of genetic and environmental factors. Many patients with very early onset IBD are difficult to treat. The current antibiotic medication that targets gram-negative and anaerobic bacteria provides...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Karger Publishers
2017
|